Новое в лечении гиперактивного мочевого пузыря с императивным недержанием мочи у женщин

Abstract

The combination of α 1 adrenoceptor blocking agent and phosphodiesterase  inhibitor of 5 th type is efficient in treatment of women with hyperactive bladder and urge urinary incontinence, which was proved by the studies of urodynamic and microcirculation of mucous coat of bladder.